Pfizer: Our new COVID pill reduces risk of death by 89%

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

Pfizer said its COVID-19 pill reduces the risk of hospitalization or death by 89%. reports that the statement came from the US pharmaceutical giant on Friday.

No deaths were reported in patients who received the company's COVID-19 oral antiviral pill PAXLOVID in the overall study population through Day 28, compared to 10 deaths in patients who received a placebo, it said.

The study was based on data from 1,219 adults who were enrolled by Sept. 29 and had a laboratory-confirmed diagnosis of SARS-CoV-2 infection within a five-day period, as well as at least one medical condition associated with an increased risk of developing severe illness from COVID-19, it added.

The company said it will submit the study to the US' Food and Drug Administration (FDA) for emergency use authorization as soon as possible.

The news makes Pfizer the second company in the world to develop a pill against the coronavirus after Merck's oral antiviral treatment drug Molnupiravir, announced on Oct. 1.

2021.11.05 / 17:09
See also

Iran records 79 coronavirus-related deaths

Georgia confirms another 59 COVID-19 deaths

Iran records 77 coronavirus-related deaths

Armenia’s coronavirus death toll nears 7,700

Azerbaijan confirms 1,394 more COVID-19 cases

Russia detects 32,602 daily COVID-19 cases

Georgia's COVID tally exceeds 865,000

Don't panic about Omicron variant, WHO says

Omicron hazard for children: increased infection

Georgia records 67 coronavirus death cases

Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla